Faraday Future Invests $41 Million in Qualigen Therapeutics for Strategic Pivot to Cryptocurrency and Web3 Business

Electric vehicle company Faraday Future (搜索)搜索该词条 announced a $41 million strategic investment in clinical-stage cancer (搜索)搜索该疾病 therapeutics company Qualigen Therapeutics (搜索)搜索该公司, marking a dramatic pivot for the biotech firm toward cryptocurrency and Web3 business operations. The investment, revealed at Faraday Future's annual 919 event in Los Angeles on September 19, represents a significant strategic shift for both companies.

Investment Structure and Ownership

Under the private investment in public equity (PIPE) transaction, Faraday Future (搜索)搜索该词条 will invest approximately $30 million at an effective price of $2.246 per share, securing beneficial ownership of approximately 55% of Qualigen's outstanding common shares. Additionally, YT Jia, Founder and Global Co-CEO of Faraday Future, will personally invest approximately $4 million, representing ownership of about 7% of Qualigen's common stock.

"As a cornerstone investor, YT Jia has also agreed to a two-year lock-up on his personal investment," according to the companies' joint announcement. Following completion of the PIPE and stockholder approval, Faraday Future (搜索)搜索该词条 and YT Jia are expected to beneficially own over 62% of Qualigen's outstanding common stock.

Strategic Transformation and Rebranding

Qualigen Therapeutics (搜索)搜索该公司, currently a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers, plans to undergo a complete business transformation. The company expects to rebrand as CXC10, with the letters representing three distinct growth engines in the cryptocurrency space.

"QLGN expects to rebrand as CXC10, focusing on three growth engines with six potential major products for crypto/Web3 ecosystem build-up, targeting to become a top U.S. public company bridging Web2 and Web3, as well as AI and crypto," the companies stated.

Three Growth Engines Strategy

The rebranded CXC10 will focus on three primary growth engines. The first growth engine, C10, serves as the value anchor and covers the C10 Treasury, C10 Index, and a potential C10 ETF. The second growth engine is anticipated to be the BesTrade DeAI Agent, described as "a potential core product and an AI Agent of the mother exchange that helps users find the best trading paths and outcomes."

The third growth engine encompasses ecosystem tokens as "the carrier of value maximization," including two key potential products: the C10 stablecoin and the EAI+Crypto Dual-Bridge RWA product.

Management Changes and Governance

The transaction includes significant management restructuring. YT Jia will serve as Chief Advisor of Qualigen, while Jerry Wang, President of Faraday Future (搜索)搜索该词条, will be appointed as Co-CEO. FF CFO Koti Meka will assume the CFO role at Qualigen.

Faraday Future (搜索)搜索该词条 will initially have the right to nominate two of five independent directors. "If the proposal is approved at the stockholders' meeting, FF's nomination rights could increase to four of the seven seats," according to the agreement terms.

Early Performance Indicators

The C10 Treasury has already completed approximately $10 million in crypto asset allocations. "As of 6 p.m. on September 18, these positions had delivered an unrealized gain of around 7%, outperforming the C10 index overall," the companies reported. The 20% actively managed allocation has been particularly successful, beating the C10 Index.

Strategic Rationale and Industry Context

YT Jia emphasized the strategic significance of the investment, stating, "I believe that FFAI will truly become a company powered by Dual Flywheel synergy and Dual Bridge empowerment—connecting EAI with crypto, and bridging Web2 with Web3."

Kevin Richardson, CEO of Qualigen Therapeutics (搜索)搜索该公司, expressed enthusiasm for the transformation: "This is a very exciting day for all stakeholders of Qualigen Therapeutics. The company will be embracing the new economy and technology which will reshape the future. The board unanimously voted to move forward with this transformative transaction and stand behind the value FF brings to our company."

Investor Backing and Transaction Details

The PIPE financing includes participation from notable investors beyond Faraday Future (搜索)搜索该词条 and YT Jia. SIGN Foundation (搜索)搜索该词条, a blockchain technology company backed by Binance Labs (搜索)搜索该词条, Sequoia Capital (搜索)搜索该词条 (US, India, China), IDG (搜索)搜索该词条, and Circle (搜索)搜索该公司, is among the investors. SIGN Foundation has achieved "a peak token valuation of $1.35 billion" and focuses on "building software infrastructure for governments and the next generation of capital markets."

Univest Securities (搜索)搜索该词条, LLC served as sole placement agent in the transaction, with Pryor Cashman representing Faraday Future (搜索)搜索该词条 and Lucosky Brookman representing Qualigen Therapeutics (搜索)搜索该公司.

Strategic Benefits and Future Outlook

The investment structure allows Faraday Future (搜索)搜索该词条 to maintain focus on its electric vehicle strategy while enabling Qualigen to pursue growth in cryptocurrency and Web3 markets. "This structure will allow FFAI to concentrate on advancing its EV strategy while QLGN can focus on driving growth in crypto and Web3, creating strategic synergies, unlocking new financing channels, and maximizing stockholder value without additional dilution to FFAI stockholders for the crypto-related business," the companies explained.

The transaction represents a significant departure from Qualigen's traditional focus on cancer (搜索)搜索该疾病 therapeutics, positioning the company to capitalize on the growing cryptocurrency and Web3 markets while leveraging Faraday Future (搜索)搜索该词条's technological expertise and strategic vision.